Adaptive Biotechnologies (ADPT) Restructuring Costs (2024 - 2026)
Adaptive Biotechnologies (ADPT) posted Restructuring Costs of $643000.0 for Q1 2026, up 639.08% sequentially from $87000.0 in Q4 2024.
Adaptive Biotechnologies (ADPT) Restructuring Costs (2024 - 2026) Analysis & Trends
Adaptive Biotechnologies has reported Restructuring Costs for 2 years, with the latest figure at $643000.0 in Q1 2026.
- Quarterly Restructuring Costs changed N/A year-over-year to $643000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $923000.0 (down 3.85% YoY) and the FY2024 annual result came in at $2.0 million, changed N/A from the prior year.
- Restructuring Costs rose to $643000.0 in Q1 2026 per ADPT's latest filing, from $87000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $1.0 million in Q1 2024 and troughed at $87000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 643,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | 193,000.00 |
| Jun 30, 2024 | 680,000.00 |
| Mar 31, 2024 | 1.04 Mn |